Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul 21;14(7):e242991.
doi: 10.1136/bcr-2021-242991.

Neonatal polycystic kidney disease: a novel variant

Affiliations
Case Reports

Neonatal polycystic kidney disease: a novel variant

Catherine Finnegan et al. BMJ Case Rep. .

Abstract

Polycystic kidney disease (PKD) is a condition typified by multiple renal cysts and renal enlargement. Classification is usually determined by mode of inheritance-autosomal dominant PKD (ADPKD) or autosomal recessive PKD (ARPKD). ARPKD frequently presents in fetal life, but here we report a rare case of a family with two siblings diagnosed with ADPKD manifesting in utero with novel genetic findings. During the first pregnancy, enlarged cystic kidneys were noted at the gestational age (GA) of 18 weeks, which became progressively larger and anyhdramnios ensued by GA of 25 weeks. The couple opted to terminate the pregnancy. The second pregnancy similarly presented with bilateral enlarged cystic kidneys, but amniotic fluid remained normal throughout and she delivered at GA of 36 weeks. Genetic testing revealed the fetus to be heterozygous in AD PKD1, which is known to cause ADPKD and heterozygous for a hypomorphic allele for ADPKD of uncertain significance. The fetus was also found to be heterozygous in the AR PKHD1 gene with a variant not previously described in the literature. Where fetal features consistent with ARPKD are identified in the setting of familial ADPKD, this fetal manifestation of ADPKD, resulting from combined variants in the PKD1 gene, should be considered.

Keywords: materno-fetal medicine; pregnancy; renal medicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Kidneys of second fetus at 25 weeks, with normal amniotic fluid.

References

    1. Melchionda S, Palladino T, Castellana S, et al. . Expanding the mutation spectrum in 130 probands with ARPKD: identification of 62 novel Pkhd1 mutations by Sanger sequencing and MLPA analysis. J Hum Genet 2016;61:811–21. 10.1038/jhg.2016.58 - DOI - PubMed
    1. Obeidova L, Elisakova V, Stekrova J, et al. . Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease. BMC Med Genet 2014;15:41. 10.1186/1471-2350-15-41 - DOI - PMC - PubMed
    1. Rossetti S, Kubly VJ, Consugar MB, et al. . Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int 2009;75:848–55. 10.1038/ki.2008.686 - DOI - PMC - PubMed
    1. Audrézet M-P, Corbiere C, Lebbah S, et al. . Comprehensive PKD1 and PKD2 mutation analysis in prenatal autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2016;27:722–9. 10.1681/ASN.2014101051 - DOI - PMC - PubMed
    1. Zerres K, Weiss H, Bulla M, et al. . Prenatal diagnosis of an early manifestation of autosomal dominant adult-type polycystic kidney disease. Lancet 1982;2:988. 10.1016/S0140-6736(82)90187-8 - DOI - PubMed

Publication types